chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I contracted COVID-19. I had fever, sore throat, coughing, and runny nose. I also had a fever around 102 so I slept a lot. The fever broke after the 3rd day. I was taking Advil and Tylenol. I went to the doctor, and he advised that I use Mucinex and cough medication. It took a long time to test negative. It took at least 2 weeks. My symptoms were gone basically but the runny nose and coughing lingered for a while.  I sounded very nasally for at least 3 weeks.  I developed issues with sciatica round March 10, 2023. It came on very suddenly. I woke up started my morning routine, I was fine one second and the next thing I felt a jolt like feeling down my leg in my right buttocks area. I was not doing anything out of the ordinary when it happened. I was not able to get an appointment until April 06, 2023, with a specialist. So, I went to my regular doctor and was prescribed Meloxicam for 30 days. After day 5, the medication was not making a dent in the symptoms. So, the doctor advised me that I can take Tylenol Extra Strength. It is finally helping me but still not enough. Its cramping my style as I normally walk 3 miles a day. I saw the podiatrist who prescribed a muscle relaxer called Methocarbamol. If I take all 3 medications in the morning I still have pain with every step, I take and I am still pushing myself to
This spontaneous report as received from a nurse refers to multiple patients of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On unknown dates, the patients were vaccinated with unspecified number of doses of improperly stored ROTATEQ lot #M01969 with expiration date: 02-NOV-2017 and lot# M019707 with expiration date: 25-OCT-2017, orally (dose was not reported). Administered doses of ROTATEQ were exposed to 35 Fahrenheit degrees for 1 hour and 30 minutes. Data logger was involved. No adverse effects were reported. Product quality complaint (PQC) was not involved. Additional information has been requested.
Vaccine diluted with sodium chloride 0.9% (expired 1/1/2022). Pfizer manufactured the diluent and had no stability data past expiration date, therefore in the absence of this data, said to re-dose the vaccine.
About 20 min after shot felt ?funny? - started feeling strange/not well, like something was not right, kind of going into shock. Then within a min or 2 swallowing became difficult.  Gave myself injection of my son?s epi pen and had friend take me to ER. Started feeling better after epi pen so did not admit to ER. Called PCP and reported event and discuss. Did not go in to see my PCP, just discusses on phone.
This spontaneous report as received from a physician refers to a 12 months old female patient without Pertinent Medical History and Drug Reactions/Allergies. The patient was received her first dose of VARIVAX (Merck) (0.5 mL single dose vaccination, subcutaneous injection, lot # unknown) on 04-SEP-2012. No other co-suspects were reported. No concomitant medications were reported. The outcome of single macule at the injection site was reported as not recovered/not resolved. The patient sought medical attention via office visiting. Additional information has been requested.
This case was reported by a pharmacist via sales rep and described the occurrence of cardiac arrest in a male patient who received SHINGRIX for prophylaxis. On 29th July 2018, the patient received SHINGRIX. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced cardiac arrest (serious criteria hospitalization and GSK medically significant), swelling arm, fever, movement disorder and walking difficulty. On an unknown date, the outcome of the cardiac arrest, swelling arm, fever, movement disorder and walking difficulty were unknown. It was unknown if the reporter considered the cardiac arrest, swelling arm, fever, movement disorder and walking difficulty to be related to SHINGRIX. Additional information was reported as follows: The age at vaccination was not reported. The patient experienced a severe reaction after vaccination with SHINGRIX. The patient was hospitalized at the time of reporting. The reporter spoke to the patient's wife on the day of reporting in the morning, where the reporter was provided with the patient's current condition status. The patient started with arm and hand swelling, fever and progressed to difficulty in moving his left side and also difficulty in walking, the patient was taken to a local hospital by ambulance at this point. The patient was treated and sent home. The patient, soon after sending home went into a cardiac arrest. The emergency number was contacted. The patient was resuscitated; also the patient was kept in the Intensive care unit (ICU), where the patient remained there one day before the date of reporting. The patient was still hospitalized at the date of reporting. Follow up information received from pharmacist (pharmacy contact) via sales representative on 24th August 2018. The adverse event was reported to VAERS. The reporter's details were updated. The patient was still hospitalized at the time of reporting, but his condition was improving. The patient was moved from intensive care unit (ICU), into a regular room on Sunday earlier to the date of reporting. The patient's wife did not provide additional information on who the patient's care team was and the patient did not have a primary care physician. The local pharmacy was waiting for the patient to be discharged before they seek out more information, but the reporter would be kept in the loop as they had learned more. The reporter would continue to provide follow up.
I had ringing in my ears constantly, it tapers off goes away and comes back. It was in both ears now it is just in my right ears. I can hear my own heart beat or pulse in my ear.
At 10:30 AM my eyes began to swell at upper lip and below the eye. My eyes were almost swollen shut in about 15 minutes.
Information has been received from a healthcare worker referring to an unspecified number of patients of unknown age and gender. The patients' medical histories, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of PEDVAXHIB (lot # M014926, expiration date 17-FEB-2019; lot # M020102, expiration date 08-MAR-2019, dose and route not reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected as there was no consent to contact the physician.
Severe muscle aches in hands and knees. It felt like carpal tunnel but the pain wouldn?t subside with those exercises. I have never had injuries or other problems in those areas, but the pain was very intense in my hands especially. Also had the expected fever and chills and fatigue.
This spontaneous report as received from a healthcare worker refers to unspecified patients of unknown age and gender. Concurrent condition, medical history and concomitant medications were not provided. On an unknown date, the patients were vaccinated with improperly stored (Oka/Merck) VARIVAX, lot # K005429, expiry 15-APR-2016 (dose, frequency, route of administration and indication were not provided). No adverse experiences reported. The outcome of events was unknown. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
J96.00 ACUTE RESPIRATORY FAILURE 12/2/2022 PLEURAL EFFUSION J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/13/2022 PLEURAL EFFUSION J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/18/2023 PLEURAL EFFUSION J96.22 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 1/18/2023 PLEURAL EFFUSION J96.00 ACUTE RESPIRATORY FAILURE 12/2/2022 METABOLIC ENCEPHALOPATHY J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/13/2022 METABOLIC ENCEPHALOPATHY J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/18/2023 METABOLIC ENCEPHALOPATHY J96.22 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 1/18/2023 METABOLIC ENCEPHALOPATHY J96.00 ACUTE RESPIRATORY FAILURE 12/2/2022 NONALCOHOLIC CIRRHOSIS J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/13/2022 NONALCOHOLIC CIRRHOSIS J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/18/2023 NONALCOHOLIC CIRRHOSIS J96.22 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 1/18/2023 NONALCOHOLIC CIRRHOSIS
No additional Ae; Pharmacist called to report that MMR II vaccine was administered via IM route rather than SC route to 48 year old patient on 11/16/22.; Pharmacist called to report that MMR II vaccine was administered via IM route rather than SC route to 48 year old patient on 11/16/22.; This spontaneous report has been received from a pharmacist, referring a 48-year-old female patient. The patient's medical history, concurrent conditions, concomitant medications were not provided.  On 16-NOV-2022, the patient was vaccinated with measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (M-M-R II) subcutaneous injection 0.5 milliliter once (strength, lot number, and expire date were not reported) (product administered to patient of inappropriate age) indicated as prophylaxis.  The measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (M-M-R II) vaccine was administered via intramuscular rather than subcutaneously (incorrect route of product administration).   No additional adverse events were reported.
Information has been received from a consumer and a school nurse concerning 41 child patients who in approximately 1995 were each vaccinated with a dose of varicella virus vaccine live. In approximately 2003, the patients developed mild cases of chickenpox. Most of the children were in the first grade and had been vaccinated at their private pediatrician's offices in the area. The reporter noted that her elementary school was the only one out of six in the area that has experienced a chickenpox outbreak. The reporter notified the elementary school parents of the outbreak. Follow-up information from the nurse indicated that 13 of the reported 41 patients were not previously vaccinated with a dose of varicella virus vaccine live and all of the cases of chickenpox have recovered. One of the previously vaccinated patients was a 6 year old patient (Grade 03 1M) who on 03 Aug 1998 was vaccinated with a dose of varicella virus vaccine live. On 27-Feb-2003, the patient developed chickenpox. The previously vaccinated patients included two siblings in elementary school who were vaccinated by the same pediatrician and subsequently developed mild outbreaks of chickenpox. The other patients that developed chickenpox post vaccination with varicella virus vaccine live were also identified (WAES #0305USA00974, 0306USA00276, 0306USA00277, 0309USA01822 and 0309USA01823 and0309USA01825 through 0309USA01846). Additional information is not expected.
Currently 36w pregnant, EDD is induction at 39 weeks.  Presented with shortness of breath to OB and sent to the ED, had a CT scan that confirmed extensive pulmonary embolisms including  a saddle embolism.  Further studies noted a DVT in my left thigh.  I was also diagnosed with GDM a couple months prior but have been diet controlled with metformin.  Am currently being treated with lovenox.
received vaccine on 3-25-21, presented to office 4-9-21 with complaints of elevated blood pressure and elevated heart rate since receiving vaccine.  Started on metoprolol.  Recheck appt 4-23-21 and feeling much improved.
Chills, pain in arm of injection administration. General bodyaches, nausea, vomiting. Bodyaches so bad she felt she couldn't move had to crawl to bathroom. Vomited 3 times. Also with headache. 8/18 - took 2 Advil which helped headache. Able to take PO. 8/19 - Still tired but much better.
Site: Bruising at Injection Site-Mild, Site: Pain at Injection Site-Medium, Systemic: Chills-Severe, Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Weakness-Severe
Over an 8 hour span, red pussy eyes, shortness of breath, fever, stabbing pains in abdomen, developed mild pancreatitis.
About 15 minutes after injection, began having numbness, warm sensation, and itching starting at my left jaw and going into distinct areas of my left side of my face. Was unable to fully wrinkle my forehead and it felt very strange, could not close my left eye completely, could not purse my lips or drink from a straw. My ear and jaw kept itching deeply. It began to resolve within about 2 hours, but I still will have some residual weakness when I am fatigued. I did not see a doctor that day because it was Saturday PM and I did not think it was an emergency. (seemed to be facial nerve irritation-precursor of Bell's palsy?)
Fully vaccinated patient tested positive for COVID upon admission to hospital for unrelated event.  Patient admitted through ED on 07/01/21 for orthopedic needs after a fall.   No s/s COVID throughout stay.  Patient also with positive COVID test in 04/2021.
pt recvd vax & given APAP for elevated temp;pt had dazed look in eyes;hands fell to side, not responsive to verbal stimuli from mom;pt vomiting & lifeless;pt taken to hosp & had sz;t102.5
Patient redness, swelling, and pain in his right arm since receiving the vaccine on 01/18/2018. 1-19-18-1/21/18 fever with max temp of 103. Describes arm felt hot and painful especially with movement. To ER 1-22/18, physician states warmth, swelling, and hard knot were due to the vaccine administered on 1-18-18. 2/13/2017 Father reports patient has pain when he has to move his arm he states "it pops and feels like the muscle is tearing of the bone".
Follow up information received on 08 JUL 2002 provided a change in the final diagnosis from viral syndrome (expected) to pyelonephritis (unexpected). Information was received from an investigator concerning a 2 month old female enrolled in an open label, clinical trial for prophylaxis of diphtheria, tetanus pertussis, hepatitis B, polio, Haemophilus influenzae type B, and Streptococcus pneumoniae. Past medical history included hospitalization for respiratory syncytial virus at two weeks of age. She received dose one of Infanrix penta and Hib-TITER on 29 APR 2002 and her first dose of Prevnar on 16 MAY 2002. On 16 MAY 2002 she developed a fever of 101.6 degrees F. rectally, cough, congestion, and vomiting. She was hospitalized on 17 MAY 2002 for observation and further investigation. She was treated for a urinary tract infection. The fever resolved on 18 MAY 2002; however, she remained hospitalized until cultures were obtained. Blood and urine cultures were negative. WBC was 14,300 cells/mm3 with 54 neutrophils and 30 lymphocytes. A urinalysis was unremarkable. A final diagnosis of pyelonephritis was made. She was discharged on 20 MAY 2002 on amoxicillin/clavulanate. The investigator reported the pyelonephritis to be related to Prevnar. This report was received from manufacturer.
Numbness and tingling in bilateral legs and right hand and sometimes the tongue and lower lip. No treatment given yet. Was watching it to see if it would resolve on its own.
First dose COVID-19 Vaccine: Arm hurting; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 63-year-old male patient received BNT162b2 (BNT162B2), on 22Jun2021 as dose 1, single (Lot number: EW0178) at the age of 62 years intramuscular, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 22Jun2021, outcome "unknown", described as "First dose COVID-19 Vaccine: Arm hurting". Therapeutic measures were not taken as a result of vaccination site pain.  Additional information: Caller and husband got their COVID-19 vaccines together. Her husband got his COVID-19 Vaccines in the muscle because he was complaining about how long the needle was and it hurt when she was jamming the needle in there. With first COVID-19 Vaccine, complaining his left arm was hurting, which was where he got the shots. Caller figured it was just that. Patient only had two doses of COVID-19 Vaccine.
for the first shot, my upper left harm hurt pretty bad for a day and a half but lightened up and was pretty much gone after day 3-4; also, I had some mild shortness of breath the following day, just f; also, I had some mild shortness of breath the following day, just for that day, which was one of the symptoms I had when I was sick with covid; This is a spontaneous report from a contactable consumer reported for herself. A 47-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number & Expiry date not reported) via unspecified route of administration, administered in left arm on 25Jul2021 at 11:00 (at age of 47-years-old) as dose 1, single for COVID-19 Immunisation. Patient medical history include asthma, sleep apnea, COVID-19. Patient concomitant medications include atenolol, rosuvastatin calcium (Crestor), levothyroxine sodium (Synthroid), lithium, desvenlafaxine succinate monohydrate (Pristiq); all used for unspecified indication start and stop dates were not reported. Patient previously took sulfa drug and experienced allergy to it. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25Jul2021(same day of vaccination), it was reported that for the first shot, my upper left arm hurt pretty bad for a day and a half but lightened up and was pretty much gone after day 3-4; also, I had some mild shortness of breath the following day just for that day, which was one of the symptoms I had when I was sick with covid. Patient underwent lab test and procedures include sars-cov-2 test,patient diagnosed with COVID-19 prior to vaccination on unspecified date.The Patient did not receive any treatment for events. The Outcome of the events was recovered on unspecified date in 2021.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
This spontaneous report as received from a nurse refers to a 61 year old patient. Medical history and concurrent conditions were not reported. On 17-JAN-2014, the patient was vaccinated with PNEUMOVAX 23 lot #J005067; expiration date: 17-JAN-2015 (dose, strength and route were not reported). Secondary and concomitant therapies were not reported. Nurse called and stated that improperly stored PNEUMOVAX 23 was administered to patient. No adverse effects reported. On 13-JAN-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 2 hours (2 pm - 4 pm) the temperature recorded was 50 degrees F. On 18-JAN-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 2 hours (2 pm - 4 pm) the temperature recorded was 49.1 degrees F. On 10-FEB-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 6 hours (12 pm - 6 pm) the temperature recorded was 51.8 degrees F. On 16-FEB-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 5 hours (12 pm - 5 pm) the temperature recorded was 51.8 degrees F. On 22-FEB-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 4 hours (2 pm - 6 pm) the temperature recorded was 52.7 degrees F. On 09-MAR-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 2 hours (12 pm - 10 pm) the temperature recorded was 55.4 degrees F. On 15-MAR-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 6 hours (8 am - 2 pm) the temperature recorded was 50 degrees F. On 16 MAR-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 20 hours (2 am - 10 pm) the temperature recorded was 64.4 degrees F. On 17-MAR-2014, PNEUMOVAX 23 the temperature reading on the morning was 64.8 degrees F. The total of hours stored outside of recommended temperatures was 55 hours. This is one of several reports from the same reporter. Additional information has been requested.
Within an hour after getting the vaccine my body starting breaking out in hives from head to toe. I looked at my arm and my skin was turning a bluish color and I started getting cold but sweaty at the same time.  My throat felt like it was closing up and I was wheezing and could hardly breathe.  My roommate took me to the infirmary and they hooked me up to IV , I believe it was IV benadryl and I stayed there the night hooked up to the fluids until the morning.
Starting the following morning, patient experienced a rash starting on her chest and neck and then traveling to her shoulders, back, stomach, and legs. Had nausea, diarrhea, and general malaise.
According to his mother, Pt received his second dose of the Moderna COVID-19 vaccine on August 2, 2021. Two days later, on August 4, 2021, he complained of not feeling well. He could not provide specific symptoms, but said that it involved his entire body and was not like anything he had ever experienced before. The following day, on August 5, 2021 he was found unresponsive on a train. He was subsequently hospitalized and pronounced deceased on  08/09/2021.
Initial intermittent joint pain. Other cold and sinus symptoms started in February leading to intense joint pain and difficulty walking extreme shortness of breath Lofgren /multi organ sarcoidosis - dx through biopsy of mediastinal lymph nodes. Prednisone, cytotoxic drugs, 60%of hair has dumped out. Difficulty keeping pace at work. Needong to call in with exhaustion and body aches with shortness of breath intermittently.
Nausea, diarrhea, fatigue, all within 18 hours.  Resolved during the following day.  Subsequently, I experienced "night sweats" for about 7 nights. They were a new event, unrelated to hormones, medications, fever, or room temperature. I  would typically change my pajamas up to 3 times a night.
Angioedema of lips/earlobes.  Rhinorrhea/pharyngeal pruritis.  Treated with 50mg po Benadryl and 125mg Solumedrol IM and symptoms improved within 30 minutes, resolved after approx 1 hour
nasal congestion, reflux, vomiting, sore throat, chest congestion, cough, HA
Pt received vaccine at outside facility on 8/1/17. Pt presented to emergency department on 8/2/17 with complaints of swelling in right arm (injection site), fatigue, and dizziness. Pt's mother had told him that he is allergic to Td vaccine after he received it on 8/1/17. Pt was admitted overnight for observation after presentation to emergency department. Methylprednisolone 125 mg once, cetirizine 10 mg once, famotidine 20 mg once.
Within minutes of receiving flu vaccine pt began groaning in distress, c/o severe pain radiating from base of sternum into her lower back. Face became very flushed, hot, c/o SOB. BP elevated 189/74, HR 82. Oxygenation was stable at 98 %, HR remained steady. Temp 98.4. RR 20. Cool compresses to face, ice to back. after 15 mins patient was calmer, flushed, pain in back starting to dissipate. BP continued to be elevated 185/67, HR 73. Oxygen 98%. At 10:41 am patient reports she was feeling better and hungry, face pink, discharged home in care of daughter. Follow up phone call with daughter at 3:33 pm, she reports patient was feeling much better, had eaten lunch and taken her BP meds, blood pressure 126/57.
Shoulder pain and immobility.  Pain was initially localized and moderate, and eventually became severe and came to extend all the way down the arm to the tip of the middle and index fingers.  Range of motion severely curtailed.  After 1 year of treating with physical therapy, 90% cessation of pain, and 75% recovery of range of motion.  These are my own estimates.  At the one-year mark, I conclude that I have permanent damage in terms of diminished ROM.
pt recvd vax 17MAY93 & 23MAY93 devel flu-like sx w/t101-104, nausea, pharyngeal pain, vomiting, weakness & h/a; slept 22-23 hrs daily; dx strep throat; exudative pharyngo tonsillitis;